Contact
Please use this form to send email to PR contact of this press release:
New Studies Moving Ahead to Evaluate Immunosuppressive Response After Positive Data for mRNA to Address Cancers: $RGBP
TO:
David R. Koos, Ph.D.
Regen BioPharma Inc.
+1 619-722-5505